Litcius/Paper detail

Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series

Rahul S. Dalal, Kanwal Bains, Jenna Marcus, Emma McClure, Jessica R. Allegretti

2022Inflammatory Bowel Diseases19 citationsDOI

Abstract

Lay Summary In this case series, 6 patients with chronic pouchitis (n = 3), cuffitis (n = 2), or Crohn’s-like disease of the pouch (n = 1) were treated with tofacitinib. One patient achieved clinical response; however, all patients ultimately discontinued therapy due to nonresponse or adverse events.

Topics & Concepts

TofacitinibPouchitisMedicinePouchAdverse effectCrohn's diseaseInflammatory bowel diseaseGastroenterologyInternal medicineSeries (stratigraphy)DermatologyDiseaseSurgeryRheumatoid arthritisBiologyPaleontologyImmunodeficiency and Autoimmune DisordersAutoimmune and Inflammatory DisordersEosinophilic Esophagitis
Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series | Litcius